EXPANDED PHARMACOTHERAPIES FOR THE TREATMENT OF OPIATE DEPENDENCE

 

Friday, September 25, 1998

 9 a.m. to 5 p.m.

 

 

     Several countries
are using opiates for maintenance treatment,


     including:

 

     * codeine

     * morphine

     * palfium

     * buprenorphine

     * injectable
methadone


 

     Presenters
of these pharmacotherapies will include leading clinicians


     and health
officials from the Netherlands, Germany, Great Britain,


     Canada, France,
Australia, Spain, Israel and the United States


 

 

     These conferences
are sponsored by:


 

     Beth Israel
Medical Center


     Columbia University
School of Public Health


     The Lindesmith
Center of the Open Society Institute


     Montefiore
Medical Center


     The New York
Academy of Medicine


     Yale University
Center for Interdisciplinary Research on AIDS


 

 

     Fee: $40 June
6 conference


         
$50 September 25 conference


         
lunch included


 

     For on-line
registration: www.nyam.org/meded/announcements/heroin.html


 

     For further
information contact the New York Academy of Medicine at


     212-822-7237,
fax at 212-987-4735, or e-mail [email protected]


 
BACK
TO VEEP’S OFFICE

Similar Posts

  • NAMA Organizational Meeting Monday, October 8th, 7 P.M.

    Admin 09/24/2022

    NAMA Organizational Meeting Monday, October 8th, 7 P.M. Chairs Jo Sotheran, NAMA Board of Directors (Treasurer) Joycelyn Woods, NAMA Board of Directors (President) As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee). Jo Sotheran introduces the reasons…

  • |

    Page 4098 Federal Register

    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…

  • Methadone Take Home Bottle Recall

    Admin 02/17/2023

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • NAMA Policy Statement: Blind Dosing and Patient Dignity

    Admin 06/10/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…

  • |

    Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • NAMA

    Admin 04/23/2021

    Telling The Untold Methadone Success Stories This Treatment Works “There may be no more effective way to contain heroin abuse than methadone, a drug that blocks an addict’s craving. Yet new efforts to expand use of methadone have inspired new attacks on it, attacks that deny common sense.“ -The New York Times, April 8, 1990…